scholar.google.com › citations
Mar 6, 2018 · Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in ...
People also ask
What is the role of protein tyrosine phosphatase 1B?
What is the role of protein tyrosine phosphatase 1B inhibitors in type 2 diabetes mellitus?
What is the mechanism of PTP1B?
What are protein tyrosine phosphatases and their inhibitors?
Aug 30, 2018 · Identification of flavonolignans from Silybum marianum seeds as allosteric protein tyrosine phosphatase 1B inhibitors. Ningbo Qin, a , b ...
Full paper. Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in ...
Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and ...
... allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in mice ...
... allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and leptin signaling in mice. J ...
Rating
(1)
KY-226 is a potent, selective, orally active and allosteric protein tyrosine phosphatase 1B (PTP1B) inhibitor with an IC50 of 0.25 μM, and without PPARγ ...
Aug 30, 2018 · Identification of flavonolignans from Silybum marianum seeds as allosteric protein tyrosine phosphatase 1B inhibitors. Ningbo QinKey ...
Oct 7, 2021 · Shoji, et al., Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity ...
Novel Non-carboxylate Benzoylsulfonamide-Based Protein ...
www.jstage.jst.go.jp › cpb › _html › -char
Therapeutic effects of the allosteric protein tyrosine phosphatase 1B inhibitor KY-226 on experimental diabetes and obesity via enhancements in insulin and ...